These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11788432)

  • 21. Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.
    Bloudícková S; Rajnoch J; Lodererová A; Honsová E; Viklický O
    Kidney Blood Press Res; 2006; 29(1):60-6. PubMed ID: 16645304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.
    Hilgers KF; Hartner A; Porst M; Mai M; Wittmann M; Hugo C; Ganten D; Geiger H; Veelken R; Mann JF
    Kidney Int; 2000 Dec; 58(6):2408-19. PubMed ID: 11115074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of polyphenol-containing azuki bean (Vigna angularis) extract on blood pressure elevation and macrophage infiltration in the heart and kidney of spontaneously hypertensive rats.
    Sato S; Mukai Y; Yamate J; Kato J; Kurasaki M; Hatai A; Sagai M
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):43-9. PubMed ID: 18047626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
    Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension.
    Rodríguez-Iturbe B; Quiroz Y; Herrera-Acosta J; Johnson RJ; Pons HA
    J Hypertens Suppl; 2002 Jun; 20(3):S9-14. PubMed ID: 12184057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.
    Guan Z; Giddens MI; Osmond DA; Cook AK; Hobbs JL; Zhang S; Yamamoto T; Pollock JS; Pollock DM; Inscho EW
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F801-7. PubMed ID: 23269644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes.
    Biswas SK; Peixoto EB; Souza DS; de Faria JB
    Am J Nephrol; 2008; 28(1):133-42. PubMed ID: 17951995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertensive renal injury is associated with gene variation affecting immune signaling.
    Braun MC; Herring SM; Gokul N; Monita M; Bell R; Zhu Y; Gonzalez-Garay ML; Wenderfer SE; Doris PA
    Circ Cardiovasc Genet; 2014 Dec; 7(6):903-10. PubMed ID: 25366137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure.
    Pechman KR; Basile DP; Lund H; Mattson DL
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1234-9. PubMed ID: 18256138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive treatment protects against angiotensin II-induced renal damage.
    Muller DN; Shagdarsuren E; Park JK; Dechend R; Mervaala E; Hampich F; Fiebeler A; Ju X; Finckenberg P; Theuer J; Viedt C; Kreuzer J; Heidecke H; Haller H; Zenke M; Luft FC
    Am J Pathol; 2002 Nov; 161(5):1679-93. PubMed ID: 12414515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
    Saad SY; Arafah MM; Najjar TA
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats.
    Landgraf SS; Wengert M; Silva JS; Zapata-Sudo G; Sudo RT; Takiya CM; Pinheiro AA; Caruso-Neves C
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F499-510. PubMed ID: 21084406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus.
    Biswas SK; Lopes de Faria JB
    Am J Nephrol; 2006; 26(5):415-22. PubMed ID: 16960441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats.
    Robles-Vera I; de la Visitación N; Toral M; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
    Biomed Pharmacother; 2021 Mar; 135():111189. PubMed ID: 33388596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
    Dharmani M; Mustafa MR; Achike FI; Sim MK
    Eur J Pharmacol; 2007 Apr; 561(1-3):144-50. PubMed ID: 17320855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ; Jackson EK
    J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
    De Cavanagh EM; Toblli JE; Ferder L; Piotrkowski B; Stella I; Fraga CG; Inserra F
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):573-8. PubMed ID: 16309582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
    Welch WJ; Wilcox CS
    Kidney Int; 2001 Apr; 59(4):1257-63. PubMed ID: 11260386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.